Menu

Search

Philip Slavin

Philip Slavin

Associate Professor of History, University of Stirling
I was born in St Petersburg, Russia and began my university career at the Hebrew University of Jerusalem, where I pursued two concurrent degrees in History and Violin Performance. I received my PhD in Medieval History from the Centre for Medieval Studies at the University of Toronto (2008). Before joining Stirling in 2018, I spent two years as a postdoctoral fellow at the Economic Growth Center, at Yale University (2008-10), three years as a Mellon Fellow and faculty lecturer at McGill University, Montreal (2010-3) and five years as a lecturer and then senior lecturer at the University of Kent (2013-8).

When outside a classroom or his office, I enjoy listening to and playing music (be it Classical, Jazz, Rock or Folk), tasting ales and whiskies (the more obscure the better), cooking, and hiking (the further away from 'Civilization' the better). I love languages and have always been attracted to their beauty, written or spoken.

My scientific creed and research interests

Rather than seeing myself as an historian in the ‘traditional’ sense, I view myself as a ‘scientist of the past’, trained to work across disciplines and collaborate with colleagues in sciences, to promote a unified knowledge and science of the past. In my research, I use historical knowledge as a powerful tool to understand some of the most important issues and challenges that the human race and its wider bio-ecological environment face today.

My principle research interests fall into two main categories. Firstly, I am interested in the history of natural environment, economy, health, and society of the late-medieval world, with a particular focus on the British Isles within the wider North Atlantic context, and Central Asia within the wider Eurasian context. My first monograph Bread and Ale for the Brethren: The Provisioning of Norwich Cathedral Priory, c.1260-1536 (2012) offers a re-interpretation of the decline of feudal system in England, through the prism of food production and consumption by local landlords. My second monograph Experiencing Famine: A Fourteenth-Century Environmental Shock in the British Isles , recently published with Brepols, examines the Great European Famine of 1315-17 (arguably the single worst subsistence crisis in Europe in the last two millennia) as a case-study to answer the most pressing question ‘What creates famine?’ In addition, I have authored (and in some cases co-authored) 34 articles on various topics related to environmental, economic and social history of late-medieval world.

Secondly, in recent years I have expanded my interests in these topics to a global ‘deep history’ perspective, all the way from early hunters-gatherers to our contemporary world. These topics are among the most pressing and complex socio-economic, environmental and political issues that scientists, NGOs and policy makers are struggling with today. Before these issues can be solved, we need a better understanding of their determinants and dynamics in a long-run historical context. I am currently working on two large-scale monograph projects. The one will examine the historical roots of global economic inequality, in a very long run. It argues that we cannot fully appreciate the phenomenon of global economic inequality, unless we study the development of socio-economic and cultural institutions from a ‘deep history’ perspective, which follows this development from early hunter-gatherer societies to our contemporary world. The other monograph is a global history of the single most notorious killer: plague - all the way from the Late Neolithic Period until sporadic outbreaks in the 21st century. This book, too, takes a deep history perspective, to answer some most pressing questions related to the phenomenon of ‘emerging diseases’, such as ‘What makes some diseases so deadly?’ ‘What is the relationship between emerging diseases and a wider bio-ecological and climatic environment?’ ‘What makes those diseases fade and disappear – or, by contrast – re-emerge again?’

I welcome enquiries from prospective research students interested in the environmental, economic, social and medical history of late-medieval and early modern British Isles and other parts of the European and North Atlantic world.

Publications

1 

Economy

Trump Calms Markets with Assurances on Fed and Tariffs

President Trump has gone to reassure markets by indicating that he has no plans to remove Federal Reserve Chairman Jerome Powell from office, walking back previous criticisms. While he once referred to Powell as a major...

Oil Prices Climb as U.S. Sanctions Iran, Trump Eases Fed Pressure

Oil prices extended gains in early Asian trading Wednesday following fresh U.S. sanctions on Iran and a larger-than-expected drop in U.S. crude inventories. Market sentiment was also lifted after President Donald Trump...

Asian Markets Rally on Hopes of Eased U.S.-China Tariffs

Asian stocks surged on Wednesday, buoyed by Wall Street gains after U.S. President Donald Trump suggested potential reductions in trade tariffs against China. His remarks sparked investor optimism, despite lingering...

Thai Rice Exports at Risk Amid US Tariffs and India’s Market Return

Thailands rice industry is facing a double blow as U.S. President Donald Trumps tariff threats loom and India resumes rice exports, driving prices down. Daeng Donsingha, a 70-year-old Thai farmer, struggles to stay afloat...

South Korea Seeks Swift Resolution on U.S. Auto Tariffs Amid Export Decline

South Koreas Industry Minister Ahn Duk-geun announced that Seoul is pushing for a swift resolution to the 25% U.S. auto tariffs in upcoming trade talks in Washington. The high-level meeting comes after the U.S. implemented...

Politics

Kremlin Cites 'Nuances' in Ukraine Peace Talks as U.S. Mediation Wavers

The Kremlin stated Wednesday that peace talks over Ukraine still face significant challenges, with many nuances requiring resolution before any agreement can be reached. This follows the abrupt cancellation of U.S....

Peter Dutton Pledges Boost in Australia’s Defence Spending Ahead of Election

Australias opposition leader Peter Dutton has vowed to raise defence spending to 3% of GDP within a decade if elected, aiming to strengthen national security amid growing global tensions and pressure from the Trump...

Elon Musk Clarifies Role at DOGE as Tesla Faces Investor Concerns

Tesla Inc (NASDAQ:TSLA) CEO Elon Musk clarified Tuesday that he is not stepping down from the Department of Government Efficiency (DOGE), but is merely reducing his time commitment. Responding to a post on X, Musk stated,...

Trump’s Approval Hits New Low Amid Public Backlash Over Power Moves

U.S. President Donald Trumps approval rating has dropped to 42%, the lowest since his return to the White House, according to a recent Reuters/Ipsos poll. The decline reflects growing public concern over his efforts to...

Over 200 University Leaders Slam Trump Administration Over Political Interference

More than 200 presidents from U.S. colleges and universities, including Harvard, Princeton, and Columbia, have jointly denounced what they call unprecedented political interference by the Trump administration in higher...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

BMW to Integrate Chinese AI from DeepSeek in China-Made Vehicles

German automotive giant BMW (ETR:BMWG) announced it will begin integrating artificial intelligence (AI) developed by Chinese startup DeepSeek into its upcoming vehicle models in China starting later this year. The...

Tesla’s Optimus Robot Faces Delays Amid China’s Rare Earth Export Curbs

Tesla CEO Elon Musk revealed that production of the companys Optimus humanoid robot has been delayed due to Chinas new export restrictions on rare earth magnetscritical components in robotics and electric vehicles....

DOJ Targets Google’s AI-Driven Search Monopoly in Landmark Antitrust Trial

The U.S. Department of Justice has launched a historic antitrust case against Alphabets Google (NASDAQ: GOOGL), aiming to prevent the tech giant from leveraging its artificial intelligence products to strengthen its...

Amazon Pauses Some AWS Data Center Leases Amid AI Demand Slowdown

Amazon.com (NASDAQ:AMZN) has reportedly paused portions of its data center leasing negotiations for Amazon Web Services (AWS), signaling a potential slowdown in demand from major artificial intelligence (AI) clients,...

Nintendo Faces Tariff Hurdles Ahead of Switch 2 Launch

Nintendo is preparing to launch the highly anticipated Switch 2 on June 5, marking eight years since the original Switch debuted. The console, which sold over 150 million units globally, became a pandemic-era favorite....
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.